Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VICL (Vical Labs) -- Ignore unavailable to you. Want to Upgrade?

To: Scott H. Davis who wrote (952)	1/5/1999 9:10:00 PM
From: billkirn	Read Replies (1) \| Respond to of 1972

Bill and Scott: I too have been adding to my VICAL holdings during this year. It would make me a little more confident if Merck announced a vaccine trial. It has been a very long time for them to work on this without significant results. Let us hope this is the year when tangible results become visible. Bill

To: Scott H. Davis who wrote (952)	1/7/1999 2:39:00 PM
From: Don Hurst	Read Replies (1) \| Respond to of 1972

Scott, can you expand on your reasons for possibly buying IMNR? I know about the AGPH investments and have followed IMNR for a long time with poor results, I might add. I finally sold it all a couple of weeks ago after the long time CFO left and an insider sold 50k shares, half his holdings. That coupled with the lukewarm RA results plus little things like an NPR report on the AIDS epidemic in the Sub Sahara and Remune's lack of involvement in places like Africa (Remune was not part of the NPR report) plus its' very long checkered past anyway, finally made me say the hell with it! Probably a good time to buy!! Regards, Don